Analyst firms · Goldman Sachs · DBVT

Goldman Sachs DBVT price target and rating history

DBV Technologies S.A. (DBVT) · Health Care

Goldman Sachs rates DBV Technologies S.A. (DBVT) Sell with a $7.25 price target, as of its latest action on May 29, 2025. It has published 3 rating actions on DBVT since May 2022, including 0 upgrades and 2 downgrades.

Current rating
Sell
Price target
$7.25
Median target, all firms
Too few
Actions on DBVT
3

Goldman Sachs price target on DBVT

$7.25$4.38$1.502023202420252026
Goldman Sachs price target on DBVT, each point a stated target, May 2022 to May 2025.

Every Goldman Sachs rating on DBVT

How other firms rate DBVT

Each firm's latest rating and stated target in the last 12 months.

FirmRatingPrice targetDate
Cantor FitzgeraldOverweight$42Dec 15, 2025
GuggenheimBuy$35Dec 3, 2025

Questions about Goldman Sachs and DBVT

What is Goldman Sachs's price target for DBVT?
Goldman Sachs's latest stated price target for DBV Technologies S.A. (DBVT) is $7.25, from its action on May 29, 2025.
What is Goldman Sachs's rating on DBVT?
Goldman Sachs rates DBVT Sell, a bearish rating, as of May 29, 2025.
When did Goldman Sachs last change its view on DBVT?
On May 29, 2025, Goldman Sachs resumes coverage at Sell, price target $7.25.

All Goldman Sachs ratingsDBVT news and filingsEvery analyst firm

From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.